Dr. Rocio Salas-Whalen discusses the science behind Ozempic injections for weight loss. They explore the use of FDA-approved medications for weight loss, the benefits of weight loss maintenance medication, and the side effects and risks associated with these medications. They also touch on the concerns of off-label usage, the need for FDA regulation of supplements, and the importance of prioritizing patient health.

Dr. Rocio Salas-Whalen, owner of New York Endocrinology and a renowned expert in diabetes and obesity, dives into the evolving understanding of obesity as a chronic disease. She discusses its complex ties to type 2 diabetes and the rising awareness post-COVID-19. The conversation highlights groundbreaking GLP-1 and GIP medications that reshape the weight loss landscape, discussing their benefits and psychological impacts on food cravings. Dr. Salas-Whalen also addresses the challenges posed by insurance companies in treating obesity, pushing for a more proactive medical approach.

Dr. Rocio Salas-Whalen, a triple board certified physician specializing in obesity and endocrinology, shares insightful perspectives on obesity and pharmacological treatments for women. She explores the role of GLP-1 agonists like Ozempic in weight management, discussing their mechanisms and effects on appetite. The conversation also covers hormonal impacts during perimenopause and menopause, the complexity of weight loss influenced by genetics and lifestyle, and the potential benefits of testosterone therapy. Tune in for myth-busting revelations and expert advice!